E-mail Article

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.

* From Email:

* To Email:

To Email:

Email Subject Line:

Comments:

Preexisting Adenovirus Seropositivity is Not Associated with Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials

Stephenson KE et al. – Authors therefore investigated whether preexisting Ad seropositivity to 7 different Ad serotypes was associated with increased risk of HIV–1 infection in 3 HIV–1 vaccine efficacy trials. In a case–control study involving 1570 adults enrolled in the VAX003 and VAX004 trials of a recombinant protein subunit HIV–1 vaccine and in the Step study, they observed that preexisting seropositivity to multiple Ad serotypes was not intrinsically associated with increased risk of HIV–1 acquisition. [more...]

The Journal of Infectious Diseases

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Medical Student Jobs
@MDLinx Career Center
View the full listing of physician jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?